Double-blind, Randomized, Controlled Phase 1 Study of the Safety and Immunogenicity of Na-ASP-2 Hookworm Vaccine in Previously-Infected Brazilian Adults.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Hookworm vaccine (Primary)
- Indications Hookworm infections
- Focus Adverse reactions; Pharmacodynamics
- 09 Jul 2012 Biomarkers information updated
- 08 Dec 2010 Planned end date changed from 1 May 2008 to 1 Mar 2009 as reported by ClinicalTrials.gov.
- 08 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.